Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction
Sifan Chen, Ayana L. Henderson, Michael C. Petriello, et al.
Cell Metabolism (2019) Vol. 30, Iss. 6, pp. 1141-1151.e5
Open Access | Times Cited: 305

Showing 1-25 of 305 citing articles:

Gut Microbiota and Cardiovascular Disease
Marco Witkowski, Taylor L. Weeks, Stanley L. Hazen
Circulation Research (2020) Vol. 127, Iss. 4, pp. 553-570
Open Access | Times Cited: 717
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
Giovanni Targher, Christopher D. Byrne, Herbert Tilg
Gut (2020) Vol. 69, Iss. 9, pp. 1691-1705
Open Access | Times Cited: 587
Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases
Wenjing Yang, Yingzi Cong
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 4, pp. 866-877
Open Access | Times Cited: 342
Role of the gut microbiota in type 2 diabetes and related diseases
Ge Yang, Jinlong Wei, Pinyi Liu, et al.
Metabolism (2021) Vol. 117, pp. 154712-154712
Closed Access | Times Cited: 289
From Association to Causality: the Role of the Gut Microbiota and Its Functional Products on Host Metabolism
Ara Koh, Fredrik Bäckhed
Molecular Cell (2020) Vol. 78, Iss. 4, pp. 584-596
Open Access | Times Cited: 246
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
Hai Wang, Xingyu Rong, Zhao Gan, et al.
Cell Metabolism (2022) Vol. 34, Iss. 4, pp. 581-594.e8
Open Access | Times Cited: 230
TMAO: how gut microbiota contributes to heart failure
Yixin Zhang, Yuan Wang, Bingbing Ke, et al.
Translational research (2020) Vol. 228, pp. 109-125
Open Access | Times Cited: 200
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 167
Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension
Shan Jiang, Yongjie Shui, Yu Cui, et al.
Redox Biology (2021) Vol. 46, pp. 102115-102115
Open Access | Times Cited: 149
Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites
Weixuan Chen, Yanli Pang
Metabolites (2021) Vol. 11, Iss. 12, pp. 869-869
Open Access | Times Cited: 127
Metabolite interactions between host and microbiota during health and disease: Which feeds the other?
Yan Zhang, Rui Chen, DuoDuo Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114295-114295
Open Access | Times Cited: 79
Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
Christoph Grander, Felix Grabherr, Herbert Tilg
Cardiovascular Research (2023) Vol. 119, Iss. 9, pp. 1787-1798
Open Access | Times Cited: 79
A male germ-cell-specific ribosome controls male fertility
Huiling Li, Yangao Huo, Xi He, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 725-731
Closed Access | Times Cited: 74
Gut Microbiota–Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms
Tyler W. Benson, Kelsey Conrad, Xinmin S. Li, et al.
Circulation (2023) Vol. 147, Iss. 14, pp. 1079-1096
Open Access | Times Cited: 72
Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases
Luis A. Constantino‐Jonapa, Yoshua Espinoza-Palacios, Alma Reyna Escalona‐Montaño, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 431-431
Open Access | Times Cited: 43
The communication mechanism of the gut-brain axis and its effect on central nervous system diseases: A systematic review
Shengwen Lu, Qiqi Zhao, Yu Guan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117207-117207
Closed Access | Times Cited: 25
Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease
Qichen Long, Fengming Luo, Binghui Li, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 22
Trimethylamine N-oxide impairs β-cell function and glucose tolerance
Lijuan Kong, Qijin Zhao, Xiaojing Jiang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Cellular and organismal function of choline metabolism
Timothy C. Kenny, Samantha G. Scharenberg, Monther Abu-Remaileh, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 3
Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease
Nilaksh Gupta, Jennifer A. Buffa, Adam Roberts, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 40, Iss. 5, pp. 1239-1255
Open Access | Times Cited: 138
Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota
Haiyu Zhang, Jiaxing Tian, Fengmei Lian, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110857-110857
Open Access | Times Cited: 114
Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect?
Christopher Papandreou, Margret I. Moré, Aouatef Bellamine
Nutrients (2020) Vol. 12, Iss. 5, pp. 1330-1330
Open Access | Times Cited: 108
Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice
Wenchao Zhang, Aika Miikeda, Jonathan E. Zuckerman, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 103
Gut microbes in cardiovascular diseases and their potential therapeutic applications
Ling Jin, Xiaoming Shi, Jing Yang, et al.
Protein & Cell (2020) Vol. 12, Iss. 5, pp. 346-359
Open Access | Times Cited: 101
Nonlethal Inhibition of Gut Microbial Trimethylamine N‐oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure
Chelsea L. Organ, Zhen Li, Thomas E. Sharp, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 10
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top